The Science of GLP-1 Weight Loss, Demystified.

GLP-1 drugs (like Ozempic and Wegovy) mimic a natural hormone that regulates appetite and blood sugar. They reduce hunger signals, slow digestion, and produce significant weight loss in most users.

For most people, yes — but it's a smart question to ask. Serious side effects like pancreatitis are rare; the common ones are nausea and stomach upset during the first weeks, and they usually fade. Your prescriber screens your history first — that screening is the safety system working.

Brand-name GLP-1s cost $900–$1,350/month without insurance. Telehealth programs with compounded semaglutide run $149–$399/month. Insurance coverage varies widely — many plans cover GLP-1s for diabetes but not weight loss.

The most common side effects are nausea, vomiting, and diarrhea — especially during dose escalation. Most improve after 4–8 weeks. Serious side effects (pancreatitis, thyroid risk) are uncommon but real.

You likely qualify if your BMI is 30+, or 27+ with a weight-related condition like high blood pressure, prediabetes, or sleep apnea. Eligibility is broader than most people realize.

It depends on your budget, insurance, and how much support you want. Ro Body leads for insurance navigation; Found for medication flexibility; Hims/Hers for lowest upfront cost. We've scored all 9 providers.

Most people lose 2–4 lbs in month 1 as doses are lowest. By month 3 results accelerate. Clinical trials show 10–15% body weight loss over 68 weeks on semaglutide at full dose.

Coverage depends heavily on your plan and diagnosis. Most plans cover GLP-1s for type 2 diabetes (Ozempic, Mounjaro). Coverage for obesity/weight loss (Wegovy, Zepbound) is improving but still inconsistent.

Most people regain a significant portion of lost weight after stopping — studies show two-thirds regain within a year. Tapering slowly, maintaining protein intake, and strength training can help limit regain.